Lucely C. Cetina

Mexico City, DIF, Mexico

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Management of invasive cervical carcinoma in three oncology centers in Latin America: A historical cohort study.

Management of invasive cervical carcinoma in three oncology centers in Latin America: A historical cohort study.

Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
Published: April 16, 2025

Deterioration of nutritional status of patients with locally advanced cervical cancer during treatment with concomitant chemoradiotherapy.

Deterioration of nutritional status of patients with locally advanced cervical cancer during treatment with concomitant chemoradiotherapy.

Journal: Journal of human nutrition and dietetics : the official journal of the British Dietetic Association
Published: April 03, 2019

Mismatch repair protein expression and intratumoral budding in rectal cancer are associated with an increased pathological complete response to preoperative chemoradiotherapy: A case-control study.

Mismatch repair protein expression and intratumoral budding in rectal cancer are associated with an increased pathological complete response to preoperative chemoradiotherapy: A case-control study.

Journal: World journal of clinical oncology
Published: July 06, 2018

Epithelial-mesenchymal transition, proliferation, and angiogenesis in locally advanced cervical cancer treated with chemoradiotherapy.

Epithelial-mesenchymal transition, proliferation, and angiogenesis in locally advanced cervical cancer treated with chemoradiotherapy.

Journal: Cancer medicine
Published: February 03, 2016

The safety of drug treatments for cervical cancer.

The safety of drug treatments for cervical cancer.

Journal: Expert opinion on drug safety
Published: December 10, 2015

A pilot study of nimotuzumab plus single agent chemotherapy as second- or third-line treatment or more in patients with recurrent, persistent or metastatic cervical cancer.

A pilot study of nimotuzumab plus single agent chemotherapy as second- or third-line treatment or more in patients with recurrent, persistent or metastatic cervical cancer.

Journal: Cancer biology & therapy
Published: March 25, 2015

Emerging drugs for the treatment of cervical cancer.

Emerging drugs for the treatment of cervical cancer.

Journal: Expert opinion on emerging drugs
Published: January 13, 2015

New molecular targets against cervical cancer.

New molecular targets against cervical cancer.

Journal: International journal of women's health
Published: December 20, 2014

Follow-up consultations for cervical cancer patients in a Mexican cancer center. Comparison with NCCN guidelines.

Follow-up consultations for cervical cancer patients in a Mexican cancer center. Comparison with NCCN guidelines.

Journal: Asian Pacific journal of cancer prevention : APJCP
Published: November 07, 2014

Hydralazine-valproate: a repositioned drug combination for the epigenetic therapy of cancer.

Hydralazine-valproate: a repositioned drug combination for the epigenetic therapy of cancer.

Journal: Expert opinion on drug metabolism & toxicology
Published: August 27, 2014

New pharmacotherapy options for cervical cancer.

New pharmacotherapy options for cervical cancer.

Journal: Expert opinion on pharmacotherapy
Published: November 12, 2013

A randomized comparison of cisplatin and oral vinorelbine as radiosensitizers in aged or comorbid locally advanced cervical cancer patients.

A randomized comparison of cisplatin and oral vinorelbine as radiosensitizers in aged or comorbid locally advanced cervical cancer patients.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 23, 2013
Showing 1-12 of 16

Last Updated: 09/26/2026